Allurion Technologies Q3 revenue beats expectations

Allurion Technologies

12/11/2025 13:09

Overview

Allurion Q3 revenue of $2.7 mln beats analyst expectations despite a year-over-year decline

Company reduced operating expenses by 29% and operating loss by 22% year-over-year

Allurion exchanged debt for convertible preferred equity and secured $5 mln private placement

Outlook

Company did not provide specific financial guidance for future quarters or the full year

Result Drivers

REVENUE DECLINE - Year-over-year revenue decrease due to distributor transitions and lower sales and marketing investments post-restructuring

COST REDUCTION - Operating expenses and losses reduced significantly due to restructuring initiatives

BALANCE SHEET STRENGTHENING - Debt exchanged for convertible preferred equity and $5 mln private placement secured

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Revenue
Beat
$2.66 mln
$2.13 mln (3 Analysts)
Q3 Gross Profit
$1.30 mln
Q3 Income from Operations
-$9.63 mln
Q3 Operating Expenses
$10.93 mln
Q3 Pretax Profit
-$11.88 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the software peer group is "buy"

Wall Street's median 12-month price target for Allurion Technologies Inc is $6.00, about 75.2% above its November 11 closing price of $1.49

Press Release: ID:nBw1Nxwwha

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)